References
Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001;27:239–43
Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6:727–731
Elias D, Matsuhisa T, Sideris L, et al. Heated intra-operative intraperitoneal exaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 2004;15:1558–1565
Elias D, Sideris L, Pocard M, et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 2004; 15:781–785
Markmann M, Rowinsky E, Hakes T, et al. Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study. J Clin Oncol 1992; 10:1485–1491
Roviello F, Marrelli D, Neri A, et al. Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion (IHCP): Postoperative Outcome and Risk Factors for Morbidity World J Surg 2006; 30 (DOI: 10.1007/s00268-006-0038-0)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marti, W.R. Re: Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion (IHCP): Postoperative Outcome and Risk Factors for Morbidity. World J. Surg. 30, 2041–2042 (2006). https://doi.org/10.1007/s00268-006-0498-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-006-0498-2